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INTRODUCTION
Cardiovascular diseases, mainly acute coronary 
syndromes, are the most common cause of 
death in Poland. In order to improve the prog-
nosis of patients after myocardial infarction, 
the Ministry of Health in cooperation with the 
National Health Fund introduced a program of 
the coordinated post-infarction care for acute 
myocardial infarction survivors (MACAMIS) in 
Poland (Polish KOS-zawał) [1]. Post-infarction 
rehabilitation begins within 14 days of dis-
charge from the hospital. This rehabilitation 
occurs in either an inpatient ward or in a day 
rehabilitation unit after the end of the coronary 
revascularization stage (percutaneous coronary 
intervention, surgical coronary artery bypass 
graft, or hybrid treatment).Then, the annual 
plan of follow-up visits to the cardiology clinic 
was continued. During the annual follow-up, 
recommendations for secondary prevention 
of cardiovascular diseases are implemented, 
and the indications for electrotherapy (cardiac 
pacing, implantable cardioverter-defibrillator 
[ICD], or implantable cardiac resynchronization 
therapy defibrillator) are assessed [2].
During the COVID-19 pandemic, the num-
ber of hospitalizations due to acute coronary 
syndromes has decreased by around 45% [3], 
and the percentage of percutaneous coronary 
angioplasty has been reduced [4]. Access to 
healthcare services, including rehabilitation 
centers, has also been significantly reduced. 
Before the announcement of a global pan-
demic, the number of centers implementing 
the MACAMIS program in Poland has started 
to gradually increase, most likely due to the 
confirmed effectiveness in improving the 
prognosis of patients who completed the pro-
gram. In patients participating in the MACAMIS 
program, an almost 40% reduction of serious 
cardiovascular events was demonstrated at the 
one-year follow-up [5]. It has not yet been ana-
lyzed whether the SARS-CoV-2 pandemic had 
a significant influence on the number of partic-
ipants in the program in the Silesian province.
METHODS
This analysis was based on data of the Polish 
National Health Fund, collected with SILCARD 
(Silesian Cardiovascular Database). It had been 
published elsewhere [5] and was based on the 
payer’s data as per ICD-9 (procedures) and ICD-
10 (diagnoses), including all patients hospital-
ized in the cardiology, cardiac surgery, and vas-
cular surgery departments. In addition, those 
diagnosed with cardiovascular diseases, as well 
as inpatients in internal disease and intensive 
care units (ICUs) across the Silesia province. The 
analyzed period includes patients enrolled in 
the MACAMIS program from October 2017 until 
July 2020. The before COVID group includes pa-
tients enrolled in the MACAMIS program from 
20 October 2017 to 14 March 2020 (n = 9585). 
The COVID group includes patients enrolled 
in the MACAMIS program in the period from 
15 March 2020 to 31 July 2020 (n = 1226). The 
groups are independent. The study protocol 
was approved by the Ethics Committee of the 
Medical University of Silesia in Katowice.
Statistical analysis
The distribution of quantitative variables was 
checked with the Shapiro-Wilk test, ant it was 
non-normal. Thus, nonparametric Mann-Whit-
ney U tests were used, along with the Chi-
square test with a correction for Yates discon-
tinuity for qualitative variables. For the entire 
analysis, P <0.05 was considered significant. 
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The calculations were performed with the data analysis 
software system, STATISTICA version 13 (TICBO Software 
Inc., Palo Alto, CA, USA).
RESULTS AND DISCUSSION
During the first wave of the COVID-19 pandemic 
(March–April 2020), the number of hospitalizations fot 
heart attacks in the Silesian region decreased by 43%, as 
compared to the same period in 2019. Moreover, 360 pa-
tients were enrolled in the MACAMIS program in March 
2019, with 405 patients in April 2019. During the same 
period in 2020, the corresponding numbers were 150 and 
148 patients, respectively. Along with the reduction of the 
total number of patients in the MACAMIS program, the 
percentage of those hospitalized for heart attack signifi-
cantly decreased from 36% in March 2019 to 26% in March 
2020 (Supplementary material, Figure S1). Patients treated 
under the MACAMIS program during the pandemic were 
older (median 65.7 vs 66.5 years; P = 0.014), and less likely 
to have a history of chronic coronary syndrome (42.59% 
vs 33.85%; P <0.001) and coronary angioplasty (9.72% vs 
6.28%; P <0.01). More often, however, these conditions 
were accompanied by pulmonary edema during infarction 
(0.89% vs 1.71%; P = 0.009) (Table 1).
In the province of Silesia, for the first year of the MACA-
MIS program (i.e. 2018), the percentage of patients enrolled 
in the program after myocardial infarction was 36.7%, 
approaching almost 50% in the second half of 2019 [6]. 
During the first wave of the SARS-CoV-2 pandemic, this 
percentage decreased dramatically. Despite the initial 






Age, years, median (IQR) 65.7 (59.0–73.1) 66.5 (59.5–73.9) 0.014
Female sex 3124 (32.59) 369 (30.10) 0.084
CHD 4082 (42.59) 415 (33.85) <0.001
Previous MI 8977 (93.66) 1141 (93.07) 0.464
HF 1195 (12.47) 174 (14.19) 0.096
Hypertension 6472 (67.52) 805 (65.66) 0.202
Type II DM 2771 (28.91) 326 (26.59) 0.097
AF 748 (7.80) 108 (8.81) 0.241
Pulmonary edema 85 (0.89) 21 (1.71) 0.009
COPD 780 (8.14) 102 (8.32) 0.870
Asthma 698 (7.28) 78 (6.36) 0.264
CKD 421 (4.39) 50 (4.08) 0.665
Cancer history 2051 (21.40) 270 (22.02) 0.642
Stroke 318 (3.32) 43 (3.51) 0.792
Pulmonary embolism 53 (0.55) 8 (0.65) 0.814
Previous PCI 932 (9.72) 77 (6.28) <0.001
Previous CABG 99 (1.03) 6 (0.49) 0.094
PM 89 (0.93) 12 (0.98) 0.988
ICD 54 (0.56) 4 (0.33) 0.388
CRT 16 (0.17) 2 (0.16) 0.733
Dialysis 49 (0.51) 5 (0.41) 0.788
Data are presented as number (percentage) of patients unless otherwise indicated.
Abbreviations: AF, atrial fibrillation; CABG, coronary artery bypass grafting; CHD, coronary heart disease; CKD, chronic kidney disease; COPD, chronic obstructive pulmonary 
disease; CRT, cardiac resynchronization therapy; DM, diabetes mellitus; HF, heart failure; ICD, implantable cardioverter defibrillator; MI, myocardial infarction; PCI, percutaneo-
us coronary intervention; PM, pacemaker
slow increase in cases in Poland, large-scale screening for 
SARS-CoV-2 infection was carried out in Silesia, focusing 
on those working in mines and care homes. This led to the 
introduction of a number of restrictions, e.g. sanitary regu-
lations and health measures to prevent infection in medical 
facilities also lowered the number of people hospitalized for 
cardiovascular disease — not only in Poland but throughout 
Europe [7]. According to the data of the National Health 
Fund, the possibility of treatment in cardiac rehabilitation 
departments was limited. According to the terms of the 
MACAMIS program, the early cardiac rehabilitation stage 
was mandatory: inability to start cardiac rehabilitation 
resulted in patient exclusion. On the other hand, for fear of 
being infected with SARS-CoV-2, patients did not agree to 
participate in the MACAMIS program.
The COVID-19 pandemic also led to significant lim-
itations in routine services provided by the health care 
system. Preventive programs and vaccinations, as well as 
screening tests, were neglected [8]. This may have contrib-
uted to a worsening of the so-called “health deficit”. The 
MACAMIS program was the first in Poland’s multi-stage 
implementation of postinfarction care and secondary 
prevention of cardiovascular disease. Participation was 
associated with an almost 40% reduction in overall mor-
tality, and a significant reduction in cardiovascular events 
after a one-year follow-up; the reduction trend in mortality 
persisted for subsequent follow-ups. Completion of cardiac 
rehabilitation and strict outpatient care were the main 
components of the MACAMIS program, contributing to 
mortality reduction [9].
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Patients in the MACAMIS program were significantly 
older, which was related to fear of becoming infected 
during hospitalization in younger patients [10]. Older pa-
tients often manifested symptoms of pulmonary edema 
on admission, which may have resulted from extended 
time dealing with the infection, starting with the onset 
of stenocardial symptoms to coronary intervention [11]. 
Yet, patients included in the MACAMIS program had a less 
frequent history of confirmed coronary artery disease and 
coronary angioplasty. This may be explained by patients 
with multiple diseases that have a more severe course 
of myocardial infarction during the pandemic; increased 
mortality was reported in the literature [12]. Coronary artery 
disease is an independent risk factor for poor prognosis 
during SARS-CoV-2 infection [13]. Restrictions in qualifi-
cations of inpatient rehabilitation departments did not 
allow for the inclusion of those with comorbidities in the 
MACAMIS program, which could have had an impact on 
subject characteristics.
There was a significant decrease in patients who qual-
ified for the MACAMIS program during the first wave of 
the COVID-19 pandemic (March–April 2020). Along with 
proven effectiveness in reducing mortality and cardiovas-
cular events in the annual follow-up, every effort was made 
to ensure that the MACAMIS program was not limited to 
only patients in the Silesian province, despite the current 
epidemiological situation.
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